Tempus AI, Inc. (NASDAQ:TEM) is Renaissance Capital LLC's 9th Largest Position

Renaissance Capital LLC boosted its holdings in shares of Tempus AI, Inc. (NASDAQ:TEM - Free Report) by 356.4% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 112,994 shares of the company's stock after acquiring an additional 88,237 shares during the period. Tempus AI accounts for about 4.2% of Renaissance Capital LLC's investment portfolio, making the stock its 9th largest holding. Renaissance Capital LLC owned about 0.07% of Tempus AI worth $5,451,000 as of its most recent SEC filing.

A number of other large investors also recently bought and sold shares of TEM. Operose Advisors LLC bought a new stake in Tempus AI during the 4th quarter valued at about $25,000. Farther Finance Advisors LLC bought a new stake in Tempus AI during the 4th quarter valued at about $34,000. Prestige Wealth Management Group LLC increased its stake in Tempus AI by 910.4% during the 4th quarter. Prestige Wealth Management Group LLC now owns 1,071 shares of the company's stock valued at $36,000 after purchasing an additional 965 shares in the last quarter. NewEdge Advisors LLC bought a new stake in Tempus AI during the 4th quarter valued at about $49,000. Finally, First Horizon Advisors Inc. increased its stake in Tempus AI by 207.9% during the 4th quarter. First Horizon Advisors Inc. now owns 1,641 shares of the company's stock valued at $55,000 after purchasing an additional 1,108 shares in the last quarter. 24.22% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

TEM has been the subject of several research reports. Wolfe Research cut shares of Tempus AI from a "strong-buy" rating to a "hold" rating in a report on Wednesday, February 26th. Needham & Company LLC reissued a "buy" rating and set a $70.00 price objective on shares of Tempus AI in a report on Wednesday, May 7th. JPMorgan Chase & Co. cut shares of Tempus AI from an "overweight" rating to a "neutral" rating and boosted their price objective for the company from $50.00 to $55.00 in a report on Tuesday, February 25th. Morgan Stanley boosted their price objective on shares of Tempus AI from $60.00 to $65.00 and gave the company an "overweight" rating in a report on Friday, May 9th. Finally, Guggenheim reissued a "buy" rating on shares of Tempus AI in a report on Tuesday, February 25th. Six investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $63.42.

Tempus AI Stock Performance

TEM opened at $62.07 on Friday. Tempus AI, Inc. has a fifty-two week low of $22.89 and a fifty-two week high of $91.45. The stock has a market capitalization of $10.75 billion and a price-to-earnings ratio of -7.96. The company has a fifty day moving average of $53.28 and a 200 day moving average of $52.06. The company has a debt-to-equity ratio of 8.17, a quick ratio of 2.55 and a current ratio of 2.69.

Tempus AI (NASDAQ:TEM - Get Free Report) last issued its quarterly earnings data on Tuesday, May 6th. The company reported ($0.24) EPS for the quarter, topping analysts' consensus estimates of ($0.27) by $0.03. The business had revenue of $255.74 million during the quarter, compared to analysts' expectations of $248.13 million. Tempus AI's quarterly revenue was up 75.4% on a year-over-year basis. As a group, sell-side analysts forecast that Tempus AI, Inc. will post -6.15 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, CAO Ryan M. Bartolucci sold 6,073 shares of the firm's stock in a transaction dated Tuesday, May 20th. The shares were sold at an average price of $63.23, for a total value of $383,995.79. Following the completion of the sale, the chief accounting officer now owns 47,799 shares in the company, valued at approximately $3,022,330.77. This trade represents a 11.27% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO Ryan Fukushima sold 7,820 shares of the firm's stock in a transaction dated Tuesday, May 20th. The stock was sold at an average price of $63.21, for a total transaction of $494,302.20. Following the completion of the sale, the chief operating officer now owns 876,640 shares of the company's stock, valued at $55,412,414.40. This trade represents a 0.88% decrease in their position. The disclosure for this sale can be found here. Insiders sold 139,888 shares of company stock valued at $7,938,111 in the last three months. Corporate insiders own 27.60% of the company's stock.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

Want to see what other hedge funds are holding TEM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tempus AI, Inc. (NASDAQ:TEM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.